Optimize TRICARE Specialty Drug Prior Auth Workflows

The Nuances of TRICARE Specialty Drug Prior Auth

TRICARE, with its distinct regulatory framework and benefit structures, adds layers of complexity to specialty drug prior authorization. These high-cost therapies frequently straddle both medical and pharmacy benefits, necessitating accurate initial classification to ensure submissions reach the correct TRICARE channel. Misclassification often leads to significant delays and administrative burden, impacting both patient care and revenue cycles.

Common Challenges in TRICARE Specialty Drug PA

• **Benefit-side Misclassification:** Incorrectly identifying whether a specialty drug falls under the medical or pharmacy benefit for TRICARE, leading to submissions to the wrong channel.
• **Site-of-Care Policy Violations:** Submitting for infusion at a hospital outpatient department (HOPD) when TRICARE policy requires a less expensive alternative site, like an infusion center.
• **Step-Therapy Gaps:** Insufficient documentation of prior-line therapies, which are often required for biologics and other specialty drugs under TRICARE policies.
• **Specialty Pharmacy Fulfillment Delays:** After PA approval, inefficient coordination with TRICARE's specialty pharmacy partners can add days to time-to-medication.
• **Documentation Burden:** Manually gathering and submitting comprehensive clinical documentation, including diagnosis codes, J-codes, and treatment history.

Klivira's Automated Approach to TRICARE Specialty Drug PA

Klivira's platform is engineered to address the specific complexities of TRICARE specialty drug prior auth. Our automation capabilities span the entire workflow, from initial benefit determination to post-approval fulfillment coordination. By leveraging advanced policy engines and integration standards, Klivira ensures that TRICARE PA requests are accurate, complete, and routed efficiently, minimizing denials and accelerating patient access to vital specialty medications.

Key Automation Capabilities for TRICARE Specialty Drug PA

• **Automated Benefit-Side Determination:** Klivira's policy engine accurately identifies whether a specialty drug falls under the TRICARE medical or pharmacy benefit, per patient context.
• **Multi-Channel Submission:** Pharmacy-benefit specialty drugs are routed via ePA partners like CoverMyMeds or Surescripts using NCPDP SCRIPT ePA, while medical-benefit drugs utilize channels such as provider portals, X12 278, or Da Vinci PAS where available.
• **FHIR-Based Step-Therapy Documentation:** Klivira extracts medication history and treatment-response data from EMRs via FHIR MedicationRequest and Observation resources, automating step-therapy documentation.
• **Site-of-Care Policy Alignment:** Our system incorporates site-of-care logic, surfacing TRICARE policy requirements before submission to ensure compliance and avoid denials.
• **Coordinated Specialty Pharmacy Handoff:** For pharmacy-benefit drugs, Klivira streamlines the post-approval coordination with TRICARE's specialty pharmacy partners for efficient fulfillment.

Compliance and Standards for TRICARE Submissions

Navigating TRICARE prior authorization requires strict adherence to industry standards and robust data security. Klivira supports key electronic standards including NCPDP SCRIPT for pharmacy benefit ePA and X12 278 for medical benefit EDI submissions. Where available, our platform also leverages Da Vinci PAS implementation guides for FHIR-based prior authorization. When handling PHI and ePHI for TRICARE beneficiaries, organizations must ensure their processes align with HIPAA regulations. We recommend discussing specific compliance postures with your internal compliance team.

Achieving Operational Efficiency with Klivira

Implementing Klivira for TRICARE specialty drug prior auth translates directly into operational efficiency gains. By automating labor-intensive tasks and ensuring submission accuracy, clinics and health systems can significantly reduce manual effort, accelerate approval times, and improve financial outcomes. This allows PA coordinators to focus on complex cases and patient advocacy, ultimately enhancing the quality and timeliness of care for TRICARE beneficiaries.